{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:59:12Z","timestamp":1792900752607,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81971741"],"award-info":[{"award-number":["No. 81971741"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multidrug resistance is still a major obstacle to cancer treatment. The most studies are to inhibit the activity of the drug transporter P-glycoprotein (P-gp), but the effect is not ideal. Herein, a nanosystem was built based on cascade catalytic consumption of cholesterol. Cholesterol oxidase (natural enzyme, COD) was immobilized on the carrier (NH<jats:sub>2<\/jats:sub>-MIL-88B, MOF) through amide reaction, COD catalyzed the consumption of cholesterol, the reaction product H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> was further produced by the MOF with its peroxidase-like activity to produce hydroxyl radicals (\u2022OH) with killing effect. Due to the high expression of CD44 receptor on the surface of tumor cells, we encapsulated chondroitin sulfate gel shell (CS-shell) with CD44 targeting and apoptosis promoting effect on the surface of DOX@MOF-COD nanoparticles, which can accurately and efficiently deliver the drugs to the tumor site and improve the effect of reversing drug resistance. Taking drug-resistant cell membrane as \"breakthrough\", this paper will provide a new idea for reversing multidrug resistance of tumor.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s12951-022-01406-9","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T13:12:13Z","timestamp":1651497133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance"],"prefix":"10.1186","volume":"20","author":[{"given":"Bin","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3196-8471","authenticated-orcid":false,"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"1406_CR1","doi-asserted-by":"publisher","first-page":"7393","DOI":"10.1002\/adma.201403562","volume":"26","author":"Y Tian","year":"2014","unstructured":"Tian Y, Jiang X, Chen X, Shao Z, Yang W. Doxorubicin-loaded magnetic silk fibroin nanoparticles for targeted therapy of multidrug-resistant cancer. Adv Mater. 2014;26:7393\u20138.","journal-title":"Adv Mater"},{"key":"1406_CR2","doi-asserted-by":"publisher","first-page":"1700623","DOI":"10.1002\/smll.201700623","volume":"13","author":"W Cheng","year":"2017","unstructured":"Cheng W, Liang C, Xu L, Liu G, Gao N, Tao W, et al. TPGS-functionalized polydopamine-modified mesoporous silica as drug nanocarriers for enhanced lung cancer chemotherapy against multidrug resistance. Small. 2017;13:1700623.","journal-title":"Small"},{"key":"1406_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.03.014","author":"SP da Silva","year":"2021","unstructured":"da Silva SP, Caires HR, Bergantim R, Guimar\u00e3es JE, Vasconcelos MH. Mirnas mediated drug resistance in hematological malignancies. Semin Cancer Biol. 2021. https:\/\/doi.org\/10.1016\/j.semcancer.2021.03.014.","journal-title":"Semin Cancer Biol"},{"key":"1406_CR4","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1021\/acs.biomac.9b00788","volume":"20","author":"B Du","year":"2019","unstructured":"Du B, Wang Q, Yang Y, Du Q, Liu Y, Zhu W, et al. Two-way cruise nanosatellite promotes metastasis inhibition by immunochemotherapy. Biomacromol. 2019;20:2873\u201387.","journal-title":"Biomacromol"},{"key":"1406_CR5","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.addr.2013.08.004","volume":"65","author":"NR Patel","year":"2013","unstructured":"Patel NR, Pattni BS, Abouzeid AH, Torchilin VP. Nanopreparations to overcome multidrug resistance in cancer. Adv Drug Del Rev. 2013;65:1748\u201362.","journal-title":"Adv Drug Del Rev"},{"key":"1406_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jconrel.2020.05.007","volume":"323","author":"Y Li","year":"2020","unstructured":"Li Y, Xu X. Nanomedicine solutions to intricate physiological-pathological barriers and molecular mechanisms of tumor multidrug resistance. J Control Release. 2020;323:483\u2013501.","journal-title":"J Control Release"},{"key":"1406_CR7","doi-asserted-by":"publisher","first-page":"111108","DOI":"10.1016\/j.biopha.2020.111108","volume":"134","author":"J Mao","year":"2021","unstructured":"Mao J, Qiu L, Ge L, Zhou J, Ji Q, Yang Y, et al. Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer. Biomed Pharmacother. 2021;134:111108.","journal-title":"Biomed Pharmacother"},{"key":"1406_CR8","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1021\/acs.molpharmaceut.7b00334","volume":"14","author":"CP Wu","year":"2017","unstructured":"Wu CP, Hsiao SH, Murakami M, Lu YJ, Li YQ, Huang YH, et al. Alpha-mangostin reverses multidrug resistance by attenuating the function of the multidrug resistance-linked ABCG2 transporter. Mol Pharm. 2017;14:2805\u201314.","journal-title":"Mol Pharm"},{"key":"1406_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrc2789","volume":"10","author":"JI Fletcher","year":"2010","unstructured":"Fletcher JI, Haber M, Henderson MJ, Norris MD. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer. 2010;10:147\u201356.","journal-title":"Nat Rev Cancer"},{"key":"1406_CR10","doi-asserted-by":"publisher","first-page":"100743","DOI":"10.1016\/j.drup.2021.100743","volume":"54","author":"JQ Wang","year":"2021","unstructured":"Wang JQ, Yang Y, Cai CY, Teng QX, Cui Q, Lin J, et al. Multidrug resistance proteins (MRPs): structure, function and the overcoming of cancer multidrug resistance. Drug Resist Updat. 2021;54:100743.","journal-title":"Drug Resist Updat"},{"key":"1406_CR11","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1080\/10717544.2016.1178825","volume":"23","author":"Y Yuan","year":"2016","unstructured":"Yuan Y, Cai T, Xia X, Zhang R, Chiba P, Cai Y. Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer. Drug Deliv. 2016;23:3350\u20137.","journal-title":"Drug Deliv"},{"key":"1406_CR12","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1002\/adfm.201100853","volume":"21","author":"Y Lee","year":"2011","unstructured":"Lee Y, Graeser R, Kratz F, Geckeler KE. Paclitaxel-loaded polymer nanoparticles for the reversal of multidrug resistance in breast cancer cells. Adv Funct Mater. 2011;21:4211\u20138.","journal-title":"Adv Funct Mater"},{"key":"1406_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2014.11.002","volume":"18","author":"RJ Kathawala","year":"2015","unstructured":"Kathawala RJ, Gupta P, Ashby CR, Chen Z-S. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resist Updates. 2015;18:1\u201317.","journal-title":"Drug Resist Updates"},{"key":"1406_CR14","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1021\/acs.molpharmaceut.9b00274","volume":"16","author":"CP Wu","year":"2019","unstructured":"Wu CP, Lusvarghi S, Wang JC, Hsiao SH, Huang YH, Hung TH, et al. Avapritinib: a selective inhibitor of kit and pdgfr\u03b1 that reverses abcb1 and ABCG2-mediated multidrug resistance in cancer cell lines. Mol Pharm. 2019;16:3040\u201352.","journal-title":"Mol Pharm"},{"key":"1406_CR15","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41590-020-0712-7","volume":"21","author":"EV Dang","year":"2020","unstructured":"Dang EV, Madhani HD, Vance RE. Cholesterol in quarantine. Nat Immunol. 2020;21:716\u20137.","journal-title":"Nat Immunol"},{"key":"1406_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.chembiol.2015.04.011","volume":"22","author":"Y Arita","year":"2015","unstructured":"Arita Y, Nishimura S, Ishitsuka R, Kishimoto T, Ikenouchi J, Ishii K, et al. Targeting cholesterol in a liquid-disordered environment by theonellamides modulates cell membrane order and cell shape. Chem Biol. 2015;22:604\u201310.","journal-title":"Chem Biol"},{"key":"1406_CR17","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.bbamem.2014.01.027","volume":"1838","author":"V Llad\u00f3","year":"2014","unstructured":"Llad\u00f3 V, L\u00f3pez DJ, Ibarguren M, Alonso M, Soriano JB, Escrib\u00e1 PV, et al. Regulation of the cancer cell membrane lipid composition by nacholeate: effects on cell signaling and therapeutical relevance in glioma. Biochim Biophys Acta. 2014;1838:1619\u201327.","journal-title":"Biochim Biophys Acta"},{"key":"1406_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrm.2017.16","volume":"18","author":"E Sezgin","year":"2017","unstructured":"Sezgin E, Levental I, Mayor S, Eggeling C. The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Bio. 2017;18:361\u201374.","journal-title":"Nat Rev Mol Cell Bio"},{"key":"1406_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson MT, Janaki-Raman S, Schulze A. Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell Metab. 2020;31:62\u201376.","journal-title":"Cell Metab"},{"key":"1406_CR20","doi-asserted-by":"publisher","first-page":"102307","DOI":"10.1016\/j.nano.2020.102307","volume":"35","author":"B Du","year":"2021","unstructured":"Du B, Zhu W, Yu L, Wang Y, Zheng M, Huang J, et al. TPGS2k-PLGA composite nanoparticles by depleting lipid rafts in colon cancer cells for overcoming drug resistance. Nanomed Nanotechnol Biol Med. 2021;35:102307.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"1406_CR21","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1021\/mp100308n","volume":"7","author":"C Peetla","year":"2010","unstructured":"Peetla C, Bhave R, Vijayaraghavalu S, Stine A, Kooijman E, Labhasetwar V. Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids. Mol Pharm. 2010;7:2334\u201348.","journal-title":"Mol Pharm"},{"key":"1406_CR22","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1021\/mp300281t","volume":"9","author":"S Vijayaraghavalu","year":"2012","unstructured":"Vijayaraghavalu S, Peetla C, Lu S, Labhasetwar V. Epigenetic modulation of the biophysical properties of drug-resistant cell lipids to restore drug transport and endocytic functions. Mol Pharm. 2012;9:2730\u201342.","journal-title":"Mol Pharm"},{"key":"1406_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.tcb.2020.01.009","volume":"30","author":"I Levental","year":"2020","unstructured":"Levental I, Levental KR, Heberle FA. Lipid rafts: controversies resolved, mysteries remain. Trends Cell Biol. 2020;30:341\u201353.","journal-title":"Trends Cell Biol"},{"key":"1406_CR24","doi-asserted-by":"publisher","first-page":"6857","DOI":"10.1111\/j.1742-4658.2009.07379.x","volume":"276","author":"L Pollegioni","year":"2009","unstructured":"Pollegioni L, Piubelli L, Molla G. Cholesterol oxidase: biotechnological applications. FEBS J. 2009;276:6857\u201370.","journal-title":"FEBS J"},{"key":"1406_CR25","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1007\/s00253-016-7497-5","volume":"100","author":"Z Moradpour","year":"2016","unstructured":"Moradpour Z, Ghasemian A. Protein engineering of microbial cholesterol oxidases: a molecular approach toward development of new enzymes with new properties. Appl Microbiol Biotechnol. 2016;100:4323\u201336.","journal-title":"Appl Microbiol Biotechnol"},{"key":"1406_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.msec.2017.03.253","volume":"77","author":"Y Huang","year":"2017","unstructured":"Huang Y, Cui L, Xue Y, Zhang S, Zhu N, Liang J, et al. Ultrasensitive cholesterol biosensor based on enzymatic silver deposition on gold nanoparticles modified screen-printed carbon electrode. Mater Sci Eng C. 2017;77:1\u20138.","journal-title":"Mater Sci Eng C"},{"key":"1406_CR27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.talanta.2018.06.041","volume":"189","author":"MZA Rahim","year":"2018","unstructured":"Rahim MZA, Govender-Hondros G, Adeloju SB. A single step electrochemical integration of gold nanoparticles, cholesterol oxidase, cholesterol esterase and mediator with polypyrrole films for fabrication of free and total cholesterol nanobiosensors. Talanta. 2018;189:418\u201328.","journal-title":"Talanta"},{"key":"1406_CR28","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1021\/acsnano.7b01530","volume":"11","author":"D Chen","year":"2017","unstructured":"Chen D, Yang D, Dougherty CA, Lu W, Wu H, He X, et al. In vivo targeting and positron emission tomography imaging of tumor with intrinsically radioactive metal\u2013organic frameworks nanomaterials. ACS Nano. 2017;11:4315\u201327.","journal-title":"ACS Nano"},{"key":"1406_CR29","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1021\/acsnano.0c09617","volume":"15","author":"R Li","year":"2021","unstructured":"Li R, Chen T, Pan X. Metal\u2013organic-framework-based materials for antimicrobial applications. ACS Nano. 2021;15:3808\u201348.","journal-title":"ACS Nano"},{"key":"1406_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1021\/acsnano.7b08056","volume":"12","author":"R Ricc\u00f2","year":"2018","unstructured":"Ricc\u00f2 R, Liang W, Li S, Gassensmith JJ, Caruso F, Doonan C, et al. Metal\u2013organic frameworks for cell and virus biology: a perspective. ACS Nano. 2018;12:13\u201323.","journal-title":"ACS Nano"},{"key":"1406_CR31","doi-asserted-by":"publisher","first-page":"1705146","DOI":"10.1002\/adma.201705146","volume":"30","author":"A Indra","year":"2018","unstructured":"Indra A, Song T, Paik U. Metal organic framework derived materials: progress and prospects for the energy conversion and storage. Adv Mater. 2018;30:1705146.","journal-title":"Adv Mater"},{"key":"1406_CR32","doi-asserted-by":"publisher","first-page":"1804131","DOI":"10.1002\/smll.201804131","volume":"15","author":"Z He","year":"2019","unstructured":"He Z, Dai Y, Li X, Guo D, Liu Y, Huang X, et al. Hybrid nanomedicine fabricated from photosensitizer-terminated metal\u2013organic framework nanoparticles for photodynamic therapy and hypoxia-activated cascade chemotherapy. Small. 2019;15:1804131.","journal-title":"Small"},{"key":"1406_CR33","doi-asserted-by":"publisher","first-page":"1902885","DOI":"10.1002\/adma.201902885","volume":"31","author":"F Liu","year":"2019","unstructured":"Liu F, Lin L, Zhang Y, Wang Y, Sheng S, Xu C, et al. A tumor-microenvironment-activated nanozyme-mediated theranostic nanoreactor for imaging-guided combined tumor therapy. Adv Mater. 2019;31:1902885.","journal-title":"Adv Mater"},{"key":"1406_CR34","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1021\/acs.accounts.8b00011","volume":"51","author":"Z Chen","year":"2018","unstructured":"Chen Z, Wang Z, Ren J, Qu X. Enzyme mimicry for combating bacteria and biofilms. Acc Chem Res. 2018;51:789\u201399.","journal-title":"Acc Chem Res"},{"key":"1406_CR35","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.1002\/anie.201605296","volume":"55","author":"Z Chen","year":"2016","unstructured":"Chen Z, Ji H, Liu C, Bing W, Wang Z, Qu X. A multinuclear metal complex based dnase-mimetic artificial enzyme: matrix cleavage for combating bacterial biofilms. Angew Chem Int Ed. 2016;55:10732\u20136.","journal-title":"Angew Chem Int Ed"},{"key":"1406_CR36","doi-asserted-by":"publisher","first-page":"22096","DOI":"10.1021\/acsami.9b03004","volume":"11","author":"W Xu","year":"2019","unstructured":"Xu W, Jiao L, Yan H, Wu Y, Chen L, Gu W, et al. Glucose oxidase-integrated metal-organic framework hybrids as biomimetic cascade nanozymes for ultrasensitive glucose biosensing. ACS Appl Mater Inter. 2019;11:22096\u2013101.","journal-title":"ACS Appl Mater Inter"},{"key":"1406_CR37","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.drudis.2021.01.029","volume":"26","author":"S Mishra","year":"2021","unstructured":"Mishra S, Ganguli M. Functions of, and replenishment strategies for, chondroitin sulfate in the human body. Drug Discov Today. 2021;26:1185\u201399.","journal-title":"Drug Discov Today"},{"key":"1406_CR38","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1111\/febs.14830","volume":"286","author":"P Kastana","year":"2019","unstructured":"Kastana P, Choleva E, Poimenidi E, Karamanos N, Sugahara K, Papadimitriou E. Insight into the role of chondroitin sulfate e in angiogenesis. FEBS J. 2019;286:2921\u201336.","journal-title":"FEBS J"},{"key":"1406_CR39","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1515\/revneuro-2020-0146","volume":"32","author":"JZ Lin","year":"2021","unstructured":"Lin JZ, Duan MR, Lin N, Zhao WJ. The emerging role of the chondroitin sulfate proteoglycan family in neurodegenerative diseases. Rev Neurosci. 2021;32:737\u201350.","journal-title":"Rev Neurosci"},{"key":"1406_CR40","doi-asserted-by":"publisher","first-page":"120602","DOI":"10.1016\/j.biomaterials.2020.120602","volume":"268","author":"CCL Schuurmans","year":"2021","unstructured":"Schuurmans CCL, Mihajlovic M, Hiemstra C, Ito K, Hennink WE, Vermonden T. Hyaluronic acid and chondroitin sulfate (meth)acrylate-based hydrogels for tissue engineering: Synthesis, characteristics and pre-clinical evaluation. Biomaterials. 2021;268:120602.","journal-title":"Biomaterials"},{"key":"1406_CR41","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1186\/s11671-017-2324-1","volume":"12","author":"J Wang","year":"2017","unstructured":"Wang J, Zhao W, Chen H, Qin A, Zhu P. Anti-tumor study of chondroitin sulfate-methotrexate nanogels. Nanoscale Res Lett. 2017;12:572.","journal-title":"Nanoscale Res Lett"},{"key":"1406_CR42","first-page":"1009","volume":"11","author":"RR Kudarha","year":"2020","unstructured":"Kudarha RR, Sawant KK. Chondroitin sulfate conjugation facilitates tumor cell internalization of albumin nanoparticles for brain-targeted delivery of temozolomide via CD44 receptor-mediated targeting. Drug Deliv Transl Re. 2020;11:1009\u20132008.","journal-title":"Drug Deliv Transl Re"},{"key":"1406_CR43","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1021\/acsami.8b19798","volume":"11","author":"M Zhang","year":"2019","unstructured":"Zhang M, Ma Y, Wang Z, Han Z, Gao W, Zhou Q, et al. A CD44-targeting programmable drug delivery system for enhancing and sensitizing chemotherapy to drug-resistant cancer. ACS Appl Mater Inter. 2019;11:5851\u201361.","journal-title":"ACS Appl Mater Inter"},{"key":"1406_CR44","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.joca.2010.02.017","volume":"18","author":"M Valli\u00e8res","year":"2010","unstructured":"Valli\u00e8res M, du Souich P. Modulation of inflammation by chondroitin sulfate. Osteoarthr Cartil. 2010;18:S1\u20136.","journal-title":"Osteoarthr Cartil"},{"key":"1406_CR45","doi-asserted-by":"publisher","first-page":"32962","DOI":"10.1073\/pnas.2011297117","volume":"117","author":"Z Li","year":"2020","unstructured":"Li Z, Zhu L, Sun H, Shen Y, Hu D, Wu W, et al. Fluorine assembly nanocluster breaks the shackles of immunosuppression to turn the cold tumor hot. PNAS. 2020;117:32962\u20139.","journal-title":"PNAS"},{"key":"1406_CR46","first-page":"1","volume":"6","author":"Z Li","year":"2020","unstructured":"Li Z, Wang Y, Shen Y, Qian C, Oupicky D, Sun M. Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti-PD-L1 immunotherapy. Sci Adv. 2020;6:1\u201311.","journal-title":"Sci Adv"},{"key":"1406_CR47","doi-asserted-by":"publisher","first-page":"15261","DOI":"10.1021\/la203570h","volume":"27","author":"MH Pham","year":"2011","unstructured":"Pham MH, Vuong GT, Vu AT, Do TO. Novel route to size-controlled Fe-MIL-88B-NH2 metal-organic framework nanocrystals. Langmuir. 2011;27:15261\u20137.","journal-title":"Langmuir"},{"key":"1406_CR48","doi-asserted-by":"publisher","first-page":"1907152","DOI":"10.1002\/adma.201907152","volume":"32","author":"B Yang","year":"2020","unstructured":"Yang B, Ding L, Yao H, Chen Y, Shi J. A metal\u2013organic framework (MOF) fenton nanoagent-enabled nanocatalytic cancer therapy in synergy with autophagy inhibition. Adv Mater. 2020;32:1907152.","journal-title":"Adv Mater"},{"key":"1406_CR49","doi-asserted-by":"publisher","first-page":"1500006","DOI":"10.1002\/advs.201500006","volume":"2","author":"L Shi","year":"2015","unstructured":"Shi L, Wang T, Zhang H, Chang K, Meng X, Liu H, et al. An amine-functionalized iron(iii) metal-organic framework as efficient visible-light photocatalyst for Cr(vi) reduction. Adv Sci. 2015;2:1500006.","journal-title":"Adv Sci"},{"key":"1406_CR50","doi-asserted-by":"publisher","first-page":"144616","DOI":"10.1016\/j.apsusc.2019.144616","volume":"505","author":"L Shao","year":"2020","unstructured":"Shao L, Yu Z, Li X, Li X, Zeng H, Feng X. Carbon nanodots anchored onto the metal-organic framework NH2-MIL-88B (Fe) as a novel visible light-driven photocatalyst: Photocatalytic performance and mechanism investigation. Appl Surf Sci. 2020;505:144616.","journal-title":"Appl Surf Sci"},{"key":"1406_CR51","doi-asserted-by":"publisher","first-page":"2002541","DOI":"10.1002\/smll.202002541","volume":"16","author":"HR Lee","year":"2020","unstructured":"Lee HR, Lee Y, Oh SS, Choi SQ. Ultra-stable freestanding lipid membrane array: direct visualization of dynamic membrane remodeling with cholesterol transport and enzymatic reactions. Small. 2020;16:2002541.","journal-title":"Small"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01406-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01406-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01406-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T13:15:35Z","timestamp":1651497335000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01406-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1406"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01406-9","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"1 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of Zhengzhou University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors are consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}